• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

按癌症类型划分的印度癌症病例数预测(2010 - 2020年)。

Projections of number of cancer cases in India (2010-2020) by cancer groups.

作者信息

Takiar Ramnath, Nadayil Deenu, Nandakumar A

机构信息

National Cancer Registry Programme, Indian Council of Medical Research, Bangalore, India.

出版信息

Asian Pac J Cancer Prev. 2010;11(4):1045-9.

PMID:21133622
Abstract

INTRODUCTION

Recently, NCRP (ICMR), Bangalore, has published a report on Time Trends in Cancer Incidence Rates. The report also provided projected numbers of cancer cases at the India country level for selected leadingsites.

OBJECTIVE

In the present paper, an attempt has been made to project cancer cases for India by sex, years and cancer groups.

SOURCES OF DATA

The incidence data generated by population-based cancer registries (PBCRs) at Bangalore, Barshi, Bhopal, Chennai, Delhi and Mumbai for the years 2001-2005 formed the sources of data. In addition, the latest incidence data of North Eastern Registries for the year 2005-06 were utilized.

METHODS

The crude incidence rate (CR) was considered suitable for assessing the future load of cancer cases in the country. The Linear Regression method (IARC 1991) was used to assess the time trend and the projection of rates for the periods 2010-2020. For whichever sites where trends were not found to be significant, their latest rates were taken into consideration and assumed to remain same for the period 2010-2020.

RESULTS

The total cancer cases are likely to go up from 979,786 cases in the year 2010 to 1,148,757 cases in the year 2020. The tobacco-related cancers for males are estimated to go up from 190,244 in the year 2010 to 225,241 in the year 2020. Similarly, the female cases will go up from 75,289 in year 2010 to 93,563 in the year 2020. For the year 2010, the number of cancer cases related to digestive system, for both males and females, are estimated to be 107,030 and 86,606 respectively. For, head and neck cancers, the estimates are 122,643 and 53,148 cases, respectively. and for the lymphoid and hematopoietic system (LHS), for the year 2010, are 62,648 for males and 41,591 for females. Gynecological-related cancers are estimated to go up from 153,850 in 2010 to 182,602 in 2020. Among males and females, cancer of breast alone is expected to cross the figure of 100,000 by the year 2020.

摘要

引言

最近,位于班加罗尔的印度医学研究理事会国家癌症登记处(NCRP)发表了一份关于癌症发病率时间趋势的报告。该报告还提供了印度全国范围内选定主要部位的癌症病例预测数量。

目的

在本文中,我们尝试按性别、年份和癌症类别对印度的癌症病例进行预测。

数据来源

班加罗尔、巴尔希、博帕尔、金奈、德里和孟买基于人群的癌症登记处(PBCRs)在2001 - 2005年期间生成的发病率数据构成了数据来源。此外,还使用了东北登记处2005 - 2006年的最新发病率数据。

方法

粗发病率(CR)被认为适合评估该国未来的癌症病例负担。采用线性回归方法(国际癌症研究机构,1991年)评估时间趋势以及2010 - 2020年期间的发病率预测。对于任何未发现趋势显著的部位,采用其最新发病率,并假定在2010 - 2020年期间保持不变。

结果

癌症病例总数可能从2010年的979,786例上升到2020年的1,148,757例。男性与烟草相关的癌症估计将从2010年的190,244例上升到2020年的225,241例。同样,女性病例将从2010年的75,289例上升到2020年的93,563例。2010年,男性和女性消化系统相关癌症病例估计分别为107,030例和86,606例。头颈部癌症的估计病例数分别为122,643例和53,148例。2010年,男性和女性淋巴及造血系统(LHS)相关癌症病例分别为62,648例和41,591例。妇科相关癌症估计将从2010年的153,850例上升到2020年的182,602例。到2020年,仅男性和女性的乳腺癌病例预计都将超过100,000例。

相似文献

1
Projections of number of cancer cases in India (2010-2020) by cancer groups.按癌症类型划分的印度癌症病例数预测(2010 - 2020年)。
Asian Pac J Cancer Prev. 2010;11(4):1045-9.
2
Time trend in breast and cervix cancer of women in India - (1990-2003).印度女性乳腺癌和宫颈癌的时间趋势 - (1990 - 2003年)
Asian Pac J Cancer Prev. 2008 Oct-Dec;9(4):777-80.
3
Italian cancer figures, report 2012: Cancer in children and adolescents.《2012年意大利癌症数据报告:儿童和青少年癌症》
Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225.
4
Trends in incidence of head and neck cancers in India.印度头颈癌发病率的趋势。
Asian Pac J Cancer Prev. 2007 Oct-Dec;8(4):607-12.
5
Projection of cancer incident cases for India -till 2026.印度癌症发病病例预测——至2026年。
Asian Pac J Cancer Prev. 2013;14(7):4379-86.
6
Breast and cervical cancer risk in India: an update.印度的乳腺癌和宫颈癌风险:最新情况。
Indian J Public Health. 2014 Jan-Mar;58(1):5-10. doi: 10.4103/0019-557X.128150.
7
Burden of cancer and projections for 2016, Indian scenario: gaps in the availability of radiotherapy treatment facilities.2016年印度癌症负担及预测:放射治疗设施可及性方面的差距
Asian Pac J Cancer Prev. 2008 Oct-Dec;9(4):671-7.
8
What is the Most Suitable Time Period to Assess the Time Trends in Cancer Incidence Rates to Make Valid Predictions--an Empirical Approach.评估癌症发病率时间趋势以进行有效预测的最合适时间段是什么——一种实证方法。
Asian Pac J Cancer Prev. 2015;16(8):3097-100. doi: 10.7314/apjcp.2015.16.8.3097.
9
Trends in breast and cervical cancer in India under National Cancer Registry Programme: An Age-Period-Cohort analysis.印度国家癌症登记计划下乳腺癌和宫颈癌的趋势:年龄-时期-队列分析
Cancer Epidemiol. 2021 Oct;74:101982. doi: 10.1016/j.canep.2021.101982. Epub 2021 Jul 16.
10
Epidemiology of breast cancer in Indian women.印度女性乳腺癌的流行病学
Asia Pac J Clin Oncol. 2017 Aug;13(4):289-295. doi: 10.1111/ajco.12661. Epub 2017 Feb 9.

引用本文的文献

1
Cancer Incidence and Mortality Across 43 Cancer Registries in India.印度43个癌症登记处的癌症发病率和死亡率
JAMA Netw Open. 2025 Aug 1;8(8):e2527805. doi: 10.1001/jamanetworkopen.2025.27805.
2
Real-World Evidence of Porto-Mesenteric Vein Resections with Pancreatectomy and the Development of Predictive Clinical Nomograms for Postoperative Outcomes-An Analysis of 389 Cases: The "Porto-Mesenteric Vein Resection-Indian MulticentrE" (PRIME) Study.胰十二指肠切除术联合门静脉-肠系膜上静脉切除的真实世界证据及术后结局预测临床列线图的开发——389例分析:“门静脉-肠系膜上静脉切除-印度多中心”(PRIME)研究
Ann Surg Oncol. 2025 Jul 5. doi: 10.1245/s10434-025-17702-1.
3
Association of Non-Tobacco Products (NTP) with Oral, Esophageal, and Pharyngeal Cancer and Oral Potentially Malignant Disorders (OPMD) in Adults: A Systematic Review and Meta-Analysis.
非烟草产品(NTP)与成人口腔、食管和咽癌及口腔潜在恶性疾病(OPMD)的关联:系统评价和荟萃分析。
Asian Pac J Cancer Prev. 2024 Oct 1;25(10):3371-3378. doi: 10.31557/APJCP.2024.25.10.3371.
4
Estimation of burden of cancer incidence and mortality in India: based on global burden of disease study 1990-2021.印度癌症发病和死亡负担的估计:基于全球疾病负担研究 1990-2021 年。
BMC Cancer. 2024 Oct 15;24(1):1278. doi: 10.1186/s12885-024-13035-6.
5
Clinicopathological Characteristics, Prognostic Factors, and Treatment Outcomes of Patients with Oral Tongue Squamous Cell Carcinoma Treated with Glossectomy: A Tertiary Oncology Center Experience.舌切除术治疗口腔舌鳞状细胞癌患者的临床病理特征、预后因素及治疗结果:一家三级肿瘤中心的经验
Indian J Otolaryngol Head Neck Surg. 2024 Oct;76(5):3845-3853. doi: 10.1007/s12070-024-04720-w. Epub 2024 May 8.
6
Emergence and impact of theranostic-nanoformulation of triple therapeutics for combination cancer therapy.用于联合癌症治疗的三联疗法诊疗纳米制剂的出现及影响
Smart Med. 2024 Jan 30;3(1):e20230035. doi: 10.1002/SMMD.20230035. eCollection 2024 Feb.
7
Progression-free survival estimation of docetaxel-based second-line treatment for advanced non-small cell lung cancer: a pooled analysis from 18 randomized control trials.多西他赛二线治疗晚期非小细胞肺癌的无进展生存期评估:18项随机对照试验的汇总分析
Front Oncol. 2024 May 14;14:1298786. doi: 10.3389/fonc.2024.1298786. eCollection 2024.
8
Significance of Serum Lactate Dehydrogenase as a Prognostic Marker and Outcome Predictor in Patients With Breast Cancer.血清乳酸脱氢酶作为乳腺癌患者预后标志物和结局预测指标的意义
Cureus. 2024 Mar 11;16(3):e55932. doi: 10.7759/cureus.55932. eCollection 2024 Mar.
9
Deoxyribose Nucleic Acid Damage and Its Association With Plasma Malondialdehyde Levels Among Patients With Cervical Cancer: A Case-Control Study.宫颈癌患者的脱氧核糖核酸损伤及其与血浆丙二醛水平的关联:一项病例对照研究。
Cureus. 2024 Jan 19;16(1):e52600. doi: 10.7759/cureus.52600. eCollection 2024 Jan.
10
Chemotherapeutic and Antiproliferative Effect of Purified Protein from Marine Catfish Tachysurus Dussumieri on Human Colon Cancer Cell Line.海洋鲶鱼(Tachysurus dussumieri)纯化蛋白对人结肠癌细胞系的化疗和抗增殖作用。
Cell Biochem Biophys. 2024 Mar;82(1):247-257. doi: 10.1007/s12013-023-01209-1. Epub 2024 Jan 6.